Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Drug Screening Market

Drug Screening Market Trends

Report ID: GMI5971
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Drug Screening Market Trend

The key factor driving the market is increased drug and alcohol consumption. For instance, as per the World Drug Report 2021 published by United Nations Office on Drugs and Crime (UNODC) in 2022, the number of people using drugs increased by 22%. The report also stated that, around 200 million people smoked cannabis in 2021, thereby increasing cannabis testing. Similarly, as per the Global Information System on Alcohol and Health (GISAH), in 2018 the worldwide total consumption was equal to 6.2 litres of pure alcohol per person in 15 years and older. Thus, the rising consumption of drugs and alcohol is expected to increase the demand for drug screening, thereby fuelling the overall market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for drug screening was USD 6.2 billion in 2022 and will reach USD 27.1 billion by 2032.

Drug screening products market share was 55.7% in 2022 attributed to the increasing launch of advanced drug screening products that provide improved solutions to make testing easy, accurate, and fast.

North America is expected to hold a significant share of the drug screening market between 2023 and 2032 due to the adverse issue of high levels of alcohol intake in the region.

Laboratory Corporation of America, Quest Diagnostics, OraSure Technologies, Inc., Thermo Fisher Scientific Inc., Lifeloc Technologies, Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd, Siemens Healthineers, and Omega Laboratories, Inc. among others.